Canakinumab Subcutaneous and Chlophedianol, dexchlorpheniramine, and pseudoephedrine
Determining the interaction of Canakinumab Subcutaneous and Chlophedianol, dexchlorpheniramine, and pseudoephedrine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: chlophedianol / dexchlorpheniramine / pseudoephedrine
Brand name: Panatuss PED, Vanacof, Panatuss PED Drops
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Chlophedianol, Dexchlorpheniramine, and Pseudoephedrine Drops
- Canakinumab Subcutaneous-Chlophedianol, Dexchlorpheniramine, and Pseudoephedrine Liquid
- Canakinumab Subcutaneous-Chlophedianol, Guaifenesin, and Phenylephrine Liquid
- Canakinumab Subcutaneous-Chlophedianol, phenylephrine, and pyrilamine
- Canakinumab Subcutaneous-Chlophedianol/Dexbrompheniramine/Phenylephrine Liquid
- Canakinumab Subcutaneous-Chlophedianol/Guaifenesin Liquid
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Canasa
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Canasa Pac rectal
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Canasa rectal
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Cancidas
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Candesartan
- Chlophedianol, dexchlorpheniramine, and pseudoephedrine-Candesartan and Hydrochlorothiazide